Literature DB >> 19056428

Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise.

Catharine H Duman1, Lee Schlesinger, Rosemarie Terwilliger, David S Russell, Samuel S Newton, Ronald S Duman.   

Abstract

Growth factors in the brain are important to depression and it's treatment and we assessed the ability of peripherally administered insulin-like growth factor-I (IGF-I) to influence behavior related to depression. We found that mice that received chronic IGF-I treatment showed antidepressant-like behavior in forced-swim and novelty-induced hypophagia (NIH) tests and increased sucrose consumption after chronic mild unpredictable stress exposure. Additionally, peripheral anti-IGF-I administration blocked exercise-induced antidepressant effects in the forced-swim test (FST). These results support the functional relevance of neurotrophic mechanisms to depression and extend this idea to include neurotrophic factors in the periphery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056428      PMCID: PMC2729431          DOI: 10.1016/j.bbr.2008.11.016

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  56 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.

Authors:  Catharine H Duman; Lee Schlesinger; Masafumi Kodama; David S Russell; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2006-08-30       Impact factor: 13.382

3.  Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.

Authors:  Brian A Hoshaw; Jessica E Malberg; Irwin Lucki
Journal:  Brain Res       Date:  2005-03-10       Impact factor: 3.252

Review 4.  Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test.

Authors:  Stephanie C Dulawa; Rene Hen
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

Review 5.  Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging.

Authors:  William E Sonntag; Melinda Ramsey; Christy S Carter
Journal:  Ageing Res Rev       Date:  2005-05       Impact factor: 10.895

Review 6.  Role of neurotrophic factors in the etiology and treatment of mood disorders.

Authors:  Ronald S Duman
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 7.  Targeting insulin-like growth factor-1 to treat Alzheimer's disease.

Authors:  Ignacio Torres-Aleman
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

8.  Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.

Authors:  Mounira Banasr; Gerald W Valentine; Xiao-Yuan Li; Shannon L Gourley; Jane R Taylor; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2007-06-21       Impact factor: 13.382

Review 9.  GDNF delivery for Parkinson's disease.

Authors:  N K Patel; S S Gill
Journal:  Acta Neurochir Suppl       Date:  2007

10.  Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice.

Authors:  Catharine H Duman; Lee Schlesinger; David S Russell; Ronald S Duman
Journal:  Brain Res       Date:  2008-01-03       Impact factor: 3.252

View more
  43 in total

1.  Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.

Authors:  Heath D Schmidt; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

Review 2.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

Review 3.  Generating new neurons to circumvent your fears: the role of IGF signaling.

Authors:  R C Agis-Balboa; A Fischer
Journal:  Cell Mol Life Sci       Date:  2013-03-30       Impact factor: 9.261

Review 4.  Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies.

Authors:  Ajaykumar N Sharma; Bruno Fernando Borges da Costa e Silva; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  J Affect Disord       Date:  2016-03-02       Impact factor: 4.839

Review 5.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

Review 6.  The many faces of insulin-like peptide signalling in the brain.

Authors:  Ana M Fernandez; Ignacio Torres-Alemán
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

Review 7.  Intermittent metabolic switching, neuroplasticity and brain health.

Authors:  Mark P Mattson; Keelin Moehl; Nathaniel Ghena; Maggie Schmaedick; Aiwu Cheng
Journal:  Nat Rev Neurosci       Date:  2018-01-11       Impact factor: 34.870

Review 8.  Neuroendocrine drivers of risk and resilience: The influence of metabolism & mitochondria.

Authors:  Susie Turkson; Alix Kloster; Peter J Hamilton; Gretchen N Neigh
Journal:  Front Neuroendocrinol       Date:  2019-07-06       Impact factor: 8.606

9.  Exercise increases mTOR signaling in brain regions involved in cognition and emotional behavior.

Authors:  Brian A Lloyd; Holly S Hake; Takayuki Ishiwata; Caroline E Farmer; Esteban C Loetz; Monika Fleshner; Sondra T Bland; Benjamin N Greenwood
Journal:  Behav Brain Res       Date:  2017-01-24       Impact factor: 3.332

10.  Voluntary wheel running does not affect lipopolysaccharide-induced depressive-like behavior in young adult and aged mice.

Authors:  Stephen A Martin; Robert Dantzer; Keith W Kelley; Jeffrey A Woods
Journal:  Neuroimmunomodulation       Date:  2013-11-20       Impact factor: 2.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.